Angiotensin-converting enzyme (ACE) inhibitors, aldosterone inhibitors and the beta blocker, carvedilol, have shown effectiveness in MI patients, but may not actually reverse the remodeling process43, 44. Here, ACE is linked to myocardial infarction.